Mirae Asset Global Etfs Holdings Ltd. Cabaletta Bio, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 21,797 shares of CABA stock, worth $97,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,797Holding current value
$97,868% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CABA
# of Institutions
142Shares Held
49.3MCall Options Held
19.9KPut Options Held
41.5K-
Jennison Associates LLC5.63MShares$25.3 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$21.4 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$17.4 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$13.6 Million0.04% of portfolio
-
Alkeon Capital Management LLC New York, NY2.62MShares$11.8 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $130M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...